Industry News
New study confirms superior sensitivity of digene HC2 HPV DNA Test vs. the other FDA-approved tests for HPV
Sep 29, 2014
A recently published study comparing three FDA-approved screening tests for human papillomavirus (HPV) provides the latest confirmation of superior sensitivity for QIAGEN's digene HC2 HPV DNA Test. Read More
Strategy to reduce side effects in modern cancer therapy
Sep 29, 2014
An interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic Chemistry) and the Medical University of Vienna (Institute for Cancer Research) has successfully... Read More
Rolapitant reduces nausea and vomiting in phase III trial
Sep 29, 2014
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time at the ESMO 2014 Congress in... Read More
Second-line afatinib significantly improves progression-free survival in recurrent or metastatic head and neck cancer, phase III trial shows
Sep 29, 2014
The tyrosine kinase inhibitor afatinib significantly improved progression-free survival compared to methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and... Read More
Anamorelin shown to improve appetite and body mass in patients with cancer anorexia-cachexia
Sep 29, 2014
A new drug, anamorelin, improves appetite and body mass in patients with advanced lung cancer who are suffering cancer anorexia and cachexia, according to phase III data presented at the ESMO 2014... Read More
Cancer during pregnancy: chemotherapy and radiotherapy are safe for babies, studies show
Sep 29, 2014
Children who are exposed to chemotherapy or radiotherapy while in the womb suffer no negative impacts on mental or cardiac development, international studies presented at the ESMO 2014 Congress in... Read More
Perjeta® (pertuzumab) first treatment for advanced breast cancer to extend survival by 15.7 months more than standard of care
Sep 29, 2014
Perjeta, in combination with Herceptin® (trastuzumab) and chemotherapy (docetaxel), can extend survival in women with previously untreated, advanced HER2-positive breast cancer to over four and... Read More
Patients taking warfarin should be able to self-monitor says NICE in new guidance
Sep 29, 2014
The National Institute for Health and Clinical Excellence (NICE) has published its diagnostics guidance on self-monitoring coagulation status in people on long term vitamin K antagonist therapy... Read More
Cancer drug plays dual purpose in regulating expression of genes in leukemia
Sep 29, 2014
Keck Medicine of USC scientists have discovered new clues about a drug instrumental in treating a certain blood cancer that may provide important targets for researchers searching for cures. Read More
Long-term protection provided by human papilloma virus vaccination
Sep 29, 2014
Every year, 11.2 of every 100 000 women in Germany develop cervical cancer. Persistent infection with a high-risk human papillomavirus (HPV) type is a necessary prerequisite for the development of... Read More
Previous Page Next Page